France had 33 cases on Wednesday “confirmed” infection with monkeypox virus, according to health authorities, Thursday, June 2. Of this total, twenty-four cases have been reported in Ile-de-France, two in Auvergne-Rhône-Alpes, one in Hauts-de-France, one in Centre-Val de Loire, four in Occitanie and one in Normandy. , according to figures from Public Health France (SPF).
This count was stopped Wednesday morning, at 10 am, specifies the public body. A new updated report will be published on Friday. The previous one, communicated on Sunday, reported sixteen confirmed cases. “The situation is changing very quickly”which justifies a device of “permanent monitoring” transmission of this virus, explained SPF.
Health Minister Brigitte Bourguignon said last week that authorities did not expect a “blaze” of the disease, and that the country had sufficient stocks of vaccines for contact cases.
Faced with cases of monkey pox, the High Authority for Health (HAS) recommended on May 24 the vaccination of adults, including health professionals, who have had risky contact with a patient. There is no specific vaccine against monkeypox, but studies have shown that smallpox vaccination is about 85% effective against monkeypox and helps reduce symptoms. World Health Organization (WHO).
These vaccines, known as first and second generations, are very effective and participated in the eradication of smallpox until 1984. But they have serious adverse effects, such as encephalitis, encephalopathies, varioliform pustulosis (or Kaposi syndrome), heart damage, etc. As the injected virus replicates in the body, they are also contraindicated in many cases, especially in pregnant women and immunocompromised people.
Monkeypox (Monkeypoxin English) or monkeypox is a disease considered rare, known in humans since 1970. It is caused by a DNA virus.